Search

Author/Creator Mohrbacher, A.

1. ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE‐155 STUDY. (12th June 2019)

Authors:
Gregory, G.; Walker, P.; Mahadevan, D.; Wang, D.; Chang, J.; Hernandez‐Ilizaliturri, F.; Klein, A.; Rybka, W.; Wagner‐Johnston, N.; Escobar, C.; Pagel, J.M.; Mohrbacher, A.; Opat, S.; Shortt, J.; Ma, H.; Gwo, J.; Farooqui, M.; Quach, H.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
328
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Paul, B.; Liedtke, M.; Siegel, D. S.; Khouri, J.; Hillenglass, J.; Rifkin, R.; Gandhi, M. D.; Kin, A.; Levy, M. Y.; Mohrbacher, A.; Schmidt, W.; Silbermann, R.; Cottini, F.; Sborov, D. W.; Walker, R.; Murphy, M.; Gu, L.; Chen, A.; Rajakumaraswamy, N.; Usmani, S. Z.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1883
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search